Important food sources of fructose-containing sugars and incident gout: a systematic review and meta-analysis of prospective cohort studies

Sabrina Ayoub-Charette, Qi Liu, Tauseef A Khan, Fei Au-Yeung, Sonia Blanco Mejia, Russell J de Souza, Thomas Ms Wolever, Lawrence A Leiter, Cyril Kendall, John L Sievenpiper, Sabrina Ayoub-Charette, Qi Liu, Tauseef A Khan, Fei Au-Yeung, Sonia Blanco Mejia, Russell J de Souza, Thomas Ms Wolever, Lawrence A Leiter, Cyril Kendall, John L Sievenpiper

Abstract

Objective: Sugar-sweetened beverages (SSBs) are associated with hyperuricaemia and gout. Whether other important food sources of fructose-containing sugars share this association is unclear.

Design: To assess the relation of important food sources of fructose-containing sugars with incident gout and hyperuricaemia, we conducted a systematic review and meta-analysis of prospective cohort studies.

Methods: We searched MEDLINE, Embase and the Cochrane Library (through 13 September 2017). We included prospective cohort studies that investigated the relationship between food sources of sugar and incident gout or hyperuricaemia. Two independent reviewers extracted relevant data and assessed the risk of bias. We pooled natural-log transformed risk ratios (RRs) using the generic inverse variance method with random effects model and expressed as RR with 95% confidence intervals (CIs). The overall certainty of the evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation system.

Results: We identified three studies (1 54 289 participants, 1761 cases of gout), comparing the highest with the lowest level of exposure for SSBs, fruit juices and fruits. No reports were found reporting incident hyperuricaemia. Fruit juice and SSB intake showed an adverse association (fruit juice: RR=1.77, 95% CI 1.20 to 2.61; SSB: RR=2.08, 95% CI 1.40 to 3.08), when comparing the highest to lowest intake of the most adjusted models. There was no significant association between fruit intake and gout (RR 0.85, 95% CI 0.63 to 1.14). The strongest evidence was for the adverse association with SSB intake (moderate certainty), and the weakest evidence was for the adverse association with fruit juice intake (very low certainty) and lack of association with fruit intake (very low certainty).

Conclusion: There is an adverse association of SSB and fruit juice intake with incident gout, which does not appear to extend to fruit intake. Further research is needed to improve our estimates.

Trial registration number: NCT02702375; Results.

Keywords: food sources of fructose containing sugars; fructose; gout; sugars; systematic review and meta-analysis; uric acid.

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Summary of evidence search and selection. Flow of the literature search for the effect of food sources of sugar intake on incident gout and hyperuricaemia. Of the 309 studies initially identified, 294 were excluded based on title and/or abstract. The remainder were read in full by two independent reviewers; after, 12 were further excluded. Included in this analysis were three prospective cohort studies.
Figure 2
Figure 2
Relation between intake of fruit, fruit juice and SSB incident gout. Estimates from most adjusted multivariate models accounting for food sources of fructose-containing sugars intake were used. The diamond represents the pooled effect estimate. Interstudy heterogeneity was tested using the Cochran Q statistic and quantified using the I2 statistic (I2 ≥50% indicative of significant heterogeneity). All results are presented as RR with 95% CI. OJ=orange juice. Other=other fruit juices. *The number of cases and participants are divided equally between the multiple entries of the study to ensure total count gives unique individuals. To overcome a unit-of-analysis error for studies appearing more than once in the same analysis, we readjusted the log-SEs to participants equally among the multiple comparisons. HPFS, Health Professionals Follow-up Study; NHS, Nurses’ Health Study; NRHS, National Runner’s Health Study; RR, risk ratio; SSB, sugar-sweetened beverage.

References

    1. Choi HK, Mount DB, Reginato AM, et al. . Pathogenesis of gout. Ann Intern Med 2005;143:499–516. 10.7326/0003-4819-143-7-200510040-00009
    1. Oparil S, Zaman MA, Calhoun DA. Pathogenesis of hypertension. Ann Intern Med 2003;139:761–76. 10.7326/0003-4819-139-9-200311040-00011
    1. Singh JA, Reddy SG, Kundukulam J. Risk factors for gout and prevention: a systematic review of the literature. Curr Opin Rheumatol 2011;23:1–202. 10.1097/BOR.0b013e3283438e13
    1. Emmerson BT. Effect of oral fructose on urate production. Ann Rheum Dis 1974;33:276–80. 10.1136/ard.33.3.276
    1. Fox IH, Kelley WN. Studies on the mechanism of fructose-induced hyperuricemia in man. Metabolism 1972;21:713–21. 10.1016/0026-0495(72)90120-5
    1. Jamnik J, Rehman S, Blanco Mejia S, et al. . Fructose intake and risk of gout and hyperuricemia: a systematic review and meta-analysis of prospective cohort studies. BMJ Open 2016;6:e013191 10.1136/bmjopen-2016-013191
    1. Trifirò G, Morabito P, Cavagna L, et al. . Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study. Ann Rheum Dis 2013;72:694–700. 10.1136/annrheumdis-2011-201254
    1. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration 2011. (cited 4 Nov 2016).
    1. Stroup DF, Berlin JA, Morton SC, et al. . Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008–12.
    1. Moher D, Liberati A, Tetzlaff J, et al. . Reprint-preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Phys Ther 2009;89:873–80.
    1. Wells GA, et al. . The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000. (cited 4 Nov 2016).
    1. Orsini N, Bellocco R, Greenland S. Generalized Least Squares for Trend Estimation of Summarized Dose–response Data. Stata J 2006;6:40–57. 10.1177/1536867X0600600103
    1. Guyatt G, Oxman AD, Akl EA, et al. . GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011;64:383–94. 10.1016/j.jclinepi.2010.04.026
    1. Guyatt GH, Oxman AD, Kunz R, et al. . GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 2011;64:395–400. 10.1016/j.jclinepi.2010.09.012
    1. Balshem H, Helfand M, Schünemann HJ, et al. . GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011;64:401–6. 10.1016/j.jclinepi.2010.07.015
    1. Guyatt GH, Oxman AD, Vist G, et al. . GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias). J Clin Epidemiol 2011;64:407–15. 10.1016/j.jclinepi.2010.07.017
    1. Guyatt GH, Oxman AD, Montori V, et al. . GRADE guidelines: 5. Rating the quality of evidence-publication bias. J Clin Epidemiol 2011;64:1277–82. 10.1016/j.jclinepi.2011.01.011
    1. Guyatt GH, Oxman AD, Kunz R, et al. . GRADE guidelines 6. Rating the quality of evidence-imprecision. J Clin Epidemiol 2011;64:1283–93. 10.1016/j.jclinepi.2011.01.012
    1. Guyatt GH, Oxman AD, Kunz R, et al. . GRADE guidelines: 7. Rating the quality of evidence-inconsistency. J Clin Epidemiol 2011;64:1294–302. 10.1016/j.jclinepi.2011.03.017
    1. Guyatt GH, Oxman AD, Kunz R, et al. . GRADE guidelines: 8. Rating the quality of evidence-indirectness. J Clin Epidemiol 2011;64:1303–10. 10.1016/j.jclinepi.2011.04.014
    1. Guyatt GH, Oxman AD, Sultan S, et al. . GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol 2011;64:1311–6. 10.1016/j.jclinepi.2011.06.004
    1. Brunetti M, Shemilt I, Pregno S, et al. . GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence. J Clin Epidemiol 2013;66:140–50. 10.1016/j.jclinepi.2012.04.012
    1. Guyatt G, Oxman AD, Sultan S, et al. . GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. J Clin Epidemiol 2013;66:151–7. 10.1016/j.jclinepi.2012.01.006
    1. Guyatt GH, Oxman AD, Santesso N, et al. . GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes. J Clin Epidemiol 2013;66:158–72. 10.1016/j.jclinepi.2012.01.012
    1. Guyatt GH, Thorlund K, Oxman AD, et al. . GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes. J Clin Epidemiol 2013;66:173–83. 10.1016/j.jclinepi.2012.08.001
    1. Choi HK, Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ 2008;336:309–12. 10.1136/
    1. Choi HK, Willett W, Curhan G. Fructose-rich beverages and risk of gout in women. JAMA 2010;304:2270–8. 10.1001/jama.2010.1638
    1. Williams PT. Effects of diet, physical activity and performance, and body weight on incident gout in ostensibly healthy, vigorously active men. Am J Clin Nutr 2008;87:1480–7. 10.1093/ajcn/87.5.1480
    1. Wallace SL, Robinson H, Masi AT, et al. . Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895–900. 10.1002/art.1780200320
    1. Vos MB, Kimmons JE, Gillespie C, et al. . Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. Medscape J Med 2008;10:160.
    1. Brisbois TD, Marsden SL, Anderson GH, et al. . Estimated intakes and sources of total and added sugars in the Canadian diet. Nutrients 2014;6:1899–912. 10.3390/nu6051899
    1. Kanbay M, Jensen T, Solak Y, et al. . Uric acid in metabolic syndrome: From an innocent bystander to a central player. Eur J Intern Med 2016;29:3–8. 10.1016/j.ejim.2015.11.026
    1. Garrett R, et al. . Biochemistry, First Canadian Edition. Toronto ON: Nelsoneducation, 2013.
    1. Choi JW, Ford ES, Gao X, et al. . Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2008;59:109–16. 10.1002/art.23245
    1. Zgaga L, Theodoratou E, Kyle J, et al. . The association of dietary intake of purine-rich vegetables, sugar-sweetened beverages and dairy with plasma urate, in a cross-sectional study. PLoS One 2012;7:e38123 10.1371/journal.pone.0038123
    1. Bomback AS, Derebail VK, Shoham DA, et al. . Sugar-sweetened soda consumption, hyperuricemia, and kidney disease. Kidney Int 2010;77:609–16. 10.1038/ki.2009.500
    1. Meneses-Leon J, Denova-Gutiérrez E, Castañón-Robles S, et al. . Sweetened beverage consumption and the risk of hyperuricemia in Mexican adults: a cross-sectional study. BMC Public Health 2014;14:445 10.1186/1471-2458-14-445
    1. Oude Griep LM, Geleijnse JM, Kromhout D, et al. . Raw and processed fruit and vegetable consumption and 10-year coronary heart disease incidence in a population-based cohort study in the Netherlands. PLoS One 2010;5:e13609 10.1371/journal.pone.0013609
    1. Imamura F, O’Connor L, Ye Z, et al. . Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. BMJ 2015;351:h3576 10.1136/bmj.h3576
    1. Gao X, Curhan G, Forman JP, et al. . Vitamin C intake and serum uric acid concentration in men. J Rheumatol 2008;35:1853–8.
    1. Jia X, Zhong L, Song Y, et al. . Consumption of citrus and cruciferous vegetables with incident type 2 diabetes mellitus based on a meta-analysis of prospective study. Prim Care Diabetes 2016;10:272–80. 10.1016/j.pcd.2015.12.004
    1. Du H, Li L, Bennett D, et al. . Fresh Fruit Consumption and Major Cardiovascular Disease in China. N Engl J Med 2016;374:1332–43. 10.1056/NEJMoa1501451
    1. Li B, Li F, Wang L, et al. . Fruit and Vegetables Consumption and Risk of Hypertension: A Meta-Analysis. J Clin Hypertens 2016;18:468–76. 10.1111/jch.12777
    1. Aune D, Giovannucci E, Boffetta P, et al. . Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality-a systematic review and dose-response meta-analysis of prospective studies. Int J Epidemiol 2017;46:1029-1056 10.1093/ije/dyw319
    1. Li M, Fan Y, Zhang X, et al. . Fruit and vegetable intake and risk of type 2 diabetes mellitus: meta-analysis of prospective cohort studies. BMJ Open 2014;4:e005497 10.1136/bmjopen-2014-005497
    1. Wang X, Ouyang Y, Liu J, et al. . Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ 2014;349:g4490 10.1136/bmj.g4490
    1. Wu L, Sun D, He Y. Fruit and vegetables consumption and incident hypertension: dose-response meta-analysis of prospective cohort studies. J Hum Hypertens 2016;30:573–80. 10.1038/jhh.2016.44
    1. Lyu LC, Hsu CY, Yeh CY, et al. . A case-control study of the association of diet and obesity with gout in Taiwan. Am J Clin Nutr 2003;78:690–701. 10.1093/ajcn/78.4.690
    1. Liu L, Lou S, Xu K, et al. . Relationship between lifestyle choices and hyperuricemia in Chinese men and women. Clin Rheumatol 2013;32:233–9. 10.1007/s10067-012-2108-z
    1. Saag KG, Choi H. Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Res Ther 2006;8 Suppl 1(Suppl 1):S2 10.1186/ar1907
    1. Choi HK. A prescription for lifestyle change in patients with hyperuricemia and gout. Curr Opin Rheumatol 2010;22:165–72. 10.1097/BOR.0b013e328335ef38
    1. Gao X, Qi L, Qiao N, et al. . Intake of added sugar and sugar-sweetened drink and serum uric acid concentration in US men and women. Hypertension 2007;50:306–12. 10.1161/HYPERTENSIONAHA.107.091041
    1. Zykova SN, et al. . Cross-sectional analysis of nutrition and serum uric acid in two Caucasian cohorts: the AusDiab Study and the Tromsø study. 2015;14:49.
    1. Reginato AM, Mount DB, Yang I, et al. . The genetics of hyperuricaemia and gout. Nat Rev Rheumatol 2012;8:610–21. 10.1038/nrrheum.2012.144
    1. Sievenpiper JL, Dworatzek PD. Food and dietary pattern-based recommendations: an emerging approach to clinical practice guidelines for nutrition therapy in diabetes. Can J Diabetes 2013;37:51–7. 10.1016/j.jcjd.2012.11.001
    1. Peixoto MR, Monego ET, Jardim PC, et al. . Diet and medication in the treatment of hyperuricemia in hypertensive patients. Arq Bras Cardiol 2001;76:468–72. 10.1590/S0066-782X2001000600004
    1. Andrews J, Guyatt G, Oxman AD, et al. . GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 2013;66:719–25. 10.1016/j.jclinepi.2012.03.013
    1. Rai SK, et al. . Trends in Gout and Rheumatoid Arthritis Hospitalizations in Canada from 2000-2011. Arthritis Care and Research 2016.
    1. Arromdee E, Michet CJ, Crowson CS, et al. . Epidemiology of gout: is the incidence rising?. J Rheumatol 2002;29:2403–2306.
    1. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011;63:3136–41. 10.1002/art.30520
    1. Wallace KL, Riedel AA, Joseph-Ridge N, et al. . Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 2004;31:1582–7.
    1. Harris CM, Lloyd DC, Lewis J. The prevalence and prophylaxis of gout in England. J Clin Epidemiol 1995;48:1153–8. 10.1016/0895-4356(94)00244-K
    1. Klemp P, Stansfield SA, Castle B, et al. . Gout is on the increase in New Zealand. Ann Rheum Dis 1997;56:22–6. 10.1136/ard.56.1.22
    1. Canada S. The 10 leading causes of death, 2011. 2015. (cited 4 Nov 2016).

Source: PubMed

3
Tilaa